The Munich-based healthtech start-up Avelios Medical has raised 30 million euros in a Series A financing round. The financing round is led by Sequoia Capital, with participation from existing investors Revent and High-Tech Gründerfonds (HTGF). Avelios Medical intends to use the new funds to drive forward the further development of its modular hospital information system (HIS) and expand its market position.
Avelios Medical offers a modern alternative to existing hospital information systems. The Munich-based start-up, founded in 2020, relies on a modular microservices architecture that can be flexibly adapted to individual hospital structures. In addition, fully structured data collection is designed to enable the efficient use of artificial intelligence in medical practice.
In view of SAP's imminent withdrawal from the market, many hospitals are facing a comprehensive conversion of their HIS systems. Avelios Medical sees this as an opportunity to accompany the change with an innovative, data-driven system. A particular focus is on reducing administrative tasks for medical staff and on the intelligent networking of patient data.
Sequoia Capital, which has already backed companies such as Google, Airbnb and Nvidia, sees great potential in Avelios Medical. “The digitization of patient care requires long-term thinking and sustainable innovation. With Sequoia, we can deliver exactly that – a system built to stand the test of time,” emphasizes Christian Albrecht, co-founder of Avelios.
Leading hospitals such as Ludwig-Maximilians-Universität München, Hannover Medical School and Sana-Kliniken already rely on Avelios software. The new investments are intended to further accelerate growth and drive forward the digital transformation in the hospital landscape.